Showing 9,341 - 9,360 results of 18,496 for search 'significantly ((((((largest decrease) OR (greater decrease))) OR (a decrease))) OR (mean decrease))', query time: 0.64s Refine Results
  1. 9341

    Wave velocity test of coal cylinder. by Qingwen Li (1510687)

    Published 2025
    “…As the net spacing ratio decreases and the number of CFRP layers increases, the peak strength and deformation capacity of the coal cylinders are significantly improved, with the maximum enhancement rate reaching up to 409.36%. …”
  2. 9342

    Specimen schematic. by Qingwen Li (1510687)

    Published 2025
    “…As the net spacing ratio decreases and the number of CFRP layers increases, the peak strength and deformation capacity of the coal cylinders are significantly improved, with the maximum enhancement rate reaching up to 409.36%. …”
  3. 9343

    Results of parameters. by Qingwen Li (1510687)

    Published 2025
    “…As the net spacing ratio decreases and the number of CFRP layers increases, the peak strength and deformation capacity of the coal cylinders are significantly improved, with the maximum enhancement rate reaching up to 409.36%. …”
  4. 9344
  5. 9345

    Metabolic characteristics of T2DM mice. by Yan Zhu (112437)

    Published 2025
    “…<div><p>Background</p><p>Type 2 diabetes mellitus (T2DM) is associated with cognitive dysfunction, which significantly impacts the quality of life. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown potential neuroprotective effects. …”
  6. 9346

    Schematic diagram of the study design. by Yan Zhu (112437)

    Published 2025
    “…<div><p>Background</p><p>Type 2 diabetes mellitus (T2DM) is associated with cognitive dysfunction, which significantly impacts the quality of life. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown potential neuroprotective effects. …”
  7. 9347

    Supplementary file 1_Protective effects and mechanism of resveratrol in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis.docx by Yajie Yin (10115902)

    Published 2025
    “…Improved fibrosis: significant reduction in pulmonary fibrosis score (SMD = −2.30, 95% CI [−2.80, −1.79], p < 0.00001, I<sup>2</sup> = 76%) and decreased Hyp content (SMD = −2.16, 95% CI [−2.69, −1.63], p < 0.00001, I<sup>2</sup> = 85%); 2. …”
  8. 9348

    Image 8_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  9. 9349

    Image 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  10. 9350

    Image 7_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  11. 9351

    Table 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.docx by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  12. 9352

    Image 4_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  13. 9353

    Image 3_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  14. 9354

    Image 2_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  15. 9355

    Image 5_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  16. 9356

    Image 6_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tif by Minyong Choi (22465405)

    Published 2025
    “…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”
  17. 9357

    Data Sheet 1_Hypocomplementemia dynamics during tocilizumab therapy in systemic juvenile idiopathic arthritis: a retrospective longitudinal study.xlsx by Jiayun Ling (15249289)

    Published 2025
    “…After 2 weeks of TCZ treatment, median (IQR) serum C3 levels declined from 1.45(1.27-1.75) g/L at baseline to 1.11 (0.97-1.18) g/L (a 23.45% reduction, P = 0.009), and C4 levels decreased from 0.29 (0.21-0.38) g/L to 0.13 (0.09-0.17) g/L (a 55.17% reduction, P = 0.005). …”
  18. 9358

    Defect-Triggered Reversible Phase Transformation for Boosting Electrochemical Performance of Coordination Polymers by Yixiu Xu (11166860)

    Published 2024
    “…Generally, if introducing defects exerted a positive effect on the property, eliminating defects would show a negative effect, and vice versa. …”
  19. 9359

    Raw data underlying the findings in this study. by Andrew Mvula (20161161)

    Published 2024
    “…The relative bone density significantly decreased as standard length and condition factor (<i>K</i>) increased in both sexes. …”
  20. 9360

    Defect-Triggered Reversible Phase Transformation for Boosting Electrochemical Performance of Coordination Polymers by Yixiu Xu (11166860)

    Published 2024
    “…Generally, if introducing defects exerted a positive effect on the property, eliminating defects would show a negative effect, and vice versa. …”